Share on

Global Proteomics Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Instrument Type, Reagents, Software & Service, Application and Region – Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 1903
Pages: 175
Formats: report pdf report excel report power bi report ppt

Proteomics Market Size (2022 to 2027)

As per our report, the global proteomics market size is estimated to grow USD 34.21 billion by 2027 from USD 19.57 billion in 2022 and is projected to grow at a Compound Annual Growth Rate (CAGR) of 11.82 % during the forecast period.

This market research report on the global proteomics market deals with proteomics which is a study of proteomes. A proteome is defined as a group of proteins produced in any biological context. Proteomics is used to investigate where and when the proteins are expressed, the rate at which proteins are produced, degraded, and how proteins are modified. It is also used to find which proteins are the cause of cancer and various other biological problems.


Y-O-Y growth in the prevalence of cancer worldwide, the use of proteomics to research cancer genes, and protein interactions in cancer genes are expected to drive the global proteomics market growth.

Additionally, factors such as application of proteomics in the diagnosis of infectious diseases, technological advancement, increase in health care expenditure, rise in awareness, rising prevalence of cancer and associated genetic disorders, increasing funding for proteomics projects, birth disorders, the demand for customized medication, increased research and development programs, and increased biotech expenditure attributing to coronavirus outbreak drives the global proteomics market growth. Therefore, the global proteomics market is expected to expand dramatically in the coming years due to technological advancements, increased research funding, growing healthcare spending, rising demand for customized medicine, and the prevalence of genetic diseases.

The growing adoption of nano-proteomics is a lucrative opportunity in the proteomics market. In the field, nanotechnology assists in studying post-translational modifications (PTM), a wide range of molecules, and the complexities of biology. As a result, the nanoproteomics area has exploded in popularity due to the use of nanostructure surfaces to isolate proteins, phosphoproteomics/metal-oxide nanoparticles, and analytical recognition of biomarker proteins. Furthermore, rising proteomics adoption in emerging economies such as China, India, and others would open new markets for the proteomics market.


Stringent government regulations, high cost of the medicines and devices, lack of professional researchers, higher cost of research and development, inadequate funding, and lack of awareness regarding the application of proteomics in developing countries are likely to restrain the global proteomics market growth to a small extent. Additionally, factors such as sequestration cuts in the U.S. & reduced funds for proteomics research, a huge disconnect between biomarker discovery & biomarker approval by regulatory authorities, expensive tools and instruments & their maintenance, reduction in free trade are expected to challenge the market during the forecast period.

Impact of COVID-19 on the global proteomics market:

The emergence of covid-19 was started in Wuhan, China. The global pandemic has affected almost all sectors of the economy. Nearly 180 countries across the globe are dealing with the pandemic. Major sectors of the economy had been negatively affected during the first half 0f 2020. In the future, this pandemic is likely to provide growth prospects. Understanding the function of proteins in the SARS-CoV-2 infection process and COVID-19 progression is critical for developing therapeutic and preventative measures. One- and two-dimensional gel electrophoresis and high-performance liquid chromatography are two of the most popular separation procedures. Mass spectrometry (MS), on the other hand, is the backbone of protein detection and identification. Other proteomic approaches (such as 2D gel-electrophoresis) that need a significant amount of pure protein for analysis have been overcome by protein identification utilizing MS methods. In addition, virus proteins that influence respiratory pathways have previously been profiled using MS-based viral peptide detection. The predominant technique for detecting viral genes in COVID-19-positive individuals is reverse transcription-polymerase chain reaction (RT-PCR). However, due to SARS-high CoV-2's mutability, RT-PCR may not be sensitive enough to identify these genes.

Furthermore, due to its high reaction times, the method has limited throughput. On the other hand, MS-based detection can enable quick and straightforward identification of SARS-CoV-2, even in recovered patients. As a result, in the eyes of COVID-19, proteomics can aid in the discovery of novel biomarkers and the definition of point-of-care procedures, potentially allowing for more cost-effective healthcare to be given closer to the patient.




Market Size Available

2021 to 2027

Base Year


Forecast Period

2022 to 2027

Segments Covered

By Waste, End-User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa


This research report on the global proteomics market has been segmented and sub-segmented based on the waste, end-user, and region.

Proteomics Market - By Instrument Type:

The protein microarray segment is expected to account for the highest proteomics market share during the forecast period based on the instrument type. It takes only a limited sample to produce multiple findings. Full protein imprinting, label-free identification, and total and direct quantification are also benefitting this technology. Protein fractionation is expected to expand at the highest rate in the near future due to its high resolution and efficient isolation of different proteins in a complex structure it provides.

Proteomics Market - By Reagents:

  • Protein Microarray Reagents
  • X-Ray Crystallography Reagents
  • Spectroscopy Reagents
  • Chromatography Reagents
  • Electrophoresis Reagents
  • Immunoassay Reagents

By 2025, the immunoassay reagents segment is predicted to account for the vast majority of the proteomics market share. The large share of this category is due to the availability of a wide range of reagents and the need for accurate, precise, and rapid disease detection at an early stage. In addition, protein fractionation reagents are expected to grow at the fastest rate in the proteomics market. This is because they help simplify the study of complex protein structures, making research faster and more efficient.

Proteomics Market - By Software & Service:

  • Analytical Laboratory Services
  • Data Analysis & Maintenance
  • Quantitation Services

Due to the effectiveness of anatomical laboratory services in the diagnosis and drug discovery, the anatomical laboratory services segment is expected to hold a significant share of the market during the forecast period.

Proteomics Market - By Application:

  • Diagnostics
  • Drug Discovery
  • Other Proteomic Application

Based on application, the Clinical Diagnostics segment accounted for the largest share in 2019 due to the increased understanding of protein expression structures for drug development and diseases.

The drug discovery segment is expected to grow at the highest CAGR due to a continuous search for efficient ways to deliver enhanced drugs.

Proteomics Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Regionally, North America dominated the global proteomics market in 2019 due to advanced research facilities' availability. Increased government spending, increased research efforts, high awareness of proteomics applications, strengthened health care facilities, high health care spending, and rising cancer incidence in the area are all factors driving market growth in North America. On the other hand, due to an increase in cancer research activities, high government support, and the presence of key market players in the region, Europe is expected to be the second leading market for proteomics during the forecast period.

However, decreasing funds in key markets like North America and Europe, sequestration cuts in the U.S. and reduced assets for proteomics research, the high cost of instruments and hardware, and lack of talented scientists are some of the major factors restraining the global proteomics market.

Asia-pacific is expected to increase at the highest CAGR due to the improving medical infrastructure, the growing influence of key players, and developing economies. In recent years, the economy of Asia has exponentially increased; this has to lead to potential new customers for the healthcare industry. Due to the effects of China's one-child policy, now a young couple needs to look after four sets of parents and many grandparents. This rise in the elderly population is projected to drive the industry, like the medical needs of the elderly are more pronounced than the younger folk. A similar problem is also being experienced in many European nations and countries like Japan. Proteomics gives an idea of what exactly is going on in the body at any state. It is like the forensics of living tissue. This helps physicians understand in greater detail the problems plaguing the patient and devise a better treatment protocol. The study also allows researchers to design better drugs as the detailed molecular picture can be accessed by looking at the proteomes. Thus, the increasing requirement for customized medicine, R&D use, technological advancements, and increased financing for proteomics ventures are some of the factors driving the global proteomics market.


Companies leading the global proteomics market profiled in the report are Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Bruker Corporation, Danaher Corporation, GE Healthcare, Luminex Corporation, Merck KGaA, PerkinElmer Inc., Thermo Fisher Scientific, Inc. and Waters Corporation.

Agilent Technologies Inc. is an American company that was established in 1999 as a spin-off of Hewlett Packard. It’s a public research, development, and manufacturing company. When the IPO for the company was released, it was the largest in Silicon Valley at that time. It is headquartered in Santa Clara, California, has more than 13,500 employees as of 2017, and reported net revenue of USD 4.5 billion in that year.


  • Proteomics succeeded where genomics had failed in this case. German doctors used a new neutrophil proteome database to diagnose two children with severe congenital neutropenia whose typical sequencing had failed.
  • Researchers from the University of Copenhagen have studied large amounts of data from tissue samples of the skin to map its molecules and functions. As a result, they have been able to create skin atlas using the data. This will help scientists understand the differences between dead skin and living skin in greater detail, allowing for better diagnosis and various diseases.
  • A group of scientists from the Centre for Genomic Regulation (CRG) in Barcelona, led by the ICREA Research Professor Luciano di Croce, Sergio Aranda, lead author and co-leader of the study, and Eduard Sabidó, head of the CRG/UPF Proteomics Unit, have identified a molecular mechanism that regulates stem cell division speed. Furthermore, this study found that AHCY protein plays an essential and irreplaceable role in human fertility.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample